This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

CTL Statement Regarding Business Operations during the COVID-19 Pandemic

Dear Valued Clients and Suppliers:

As concerns about the spread of COVID-19 increase, Cellular Technology Limited’s and CTL Analyzers, LLC’s (collectively, “CTL”) top priorities are the health and safety of our employees, customers, suppliers and others. During this pandemic, CTL has taken a number of extra precautionary safety and health measures to minimize the risk of exposure to our employees and others.

We assure you that CTL will continue to take measures to provide uninterrupted industry leading support and services to our clients and others. Although we have temporarily suspended business travel, we are fully operational, while some of our personnel will be conducting business remotely from home.

As an immune monitoring biotechnology company that provides operations, research and development, manufacturing, and supply chain services for a number of different sectors, CTL is a company that is allowed to operate and stay open under the terms of the Director’s Stay at Home Order issued by the Director of the Ohio Department of Health on March 22, 2020. CTL is part of a critical infrastructure industry, as defined by the Department of Homeland Security, in that the pharmaceutical and biotech industries are considered essential.

If you have any legal questions regarding CTL’s continued operations, please contact our attorney, Keith E. Blaha, General Counsel of CTL. He can be reached at +1-216-325-9179 or via email at keith.blaha@immunospot.com.

If you have questions regarding specific products or services, please contact our respective representatives via our regular channels.

Yours,
CTL Executive Management